RWJ-333441 Microcide/RW Johnson
Jiraskova, N.
Current Opinion in Investigational Drugs 2(2): 209-211
2001
ISSN/ISBN: 1472-4472 PMID: 11816832 Document Number: 538728
Microcide and RW Johnson Pharmaceutical Research Institute are investigating a novel cephalosporin prodrug RWJ-333442 for the potential treatment of bacterial infections. RWJ-333442 is the prodrug of RWJ-333441; it has an improved solubility profile and studies are in progress in human serum, rats and rhesus macaques [382578], [382862], [383594].